Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISIS 113715 in Type 2 Diabetes
NCT00327626Phase 2Withdrawn
- Sponsor
- Ionis Pharmaceuticals
- Start
- May 2006
- Primary completion
- Feb 2007
- Modality
- Modified DNA Oligonucleotides, Single-strand DNA, Antisense Oligonucleotides (ASOs)
- Countries
- 1
01
Overview
A Phase 2 trial of IONIS-PTP-1BRx in type 2 diabetes mellitus (T2DM), sponsored by Ionis Pharmaceuticals. Planned start May 2006; status: withdrawn.
02
Drugs
IONIS-PTP-1BRx
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00327626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327626.